MARCKSL1 Gene: Structure, Function, and Clinical Significance

A comprehensive biomedical overview of MARCKSL1 (MARCKS-like 1), a protein involved in cell motility, membrane dynamics, and neurodevelopment, with implications in cancer and neurological disorders.

Gene Information Card

Symbol MARCKSL1
Full Name MARCKS-like 1
Gene Type protein coding
Chromosomal Location 1p35.3
NCBI Gene ID 65108 ncbi.nlm.nih.gov/gene/65108
Ensembl ID ENSG00000175130
UniProt ID P49006
OMIM ID 602940
HGNC ID 7141
Aliases MLP, MacMARCKS, MARCKS-related protein

Description

MARCKSL1 (MARCKS-like 1) encodes a member of the MARCKS family of proteins. This protein binds calmodulin and actin, and is involved in cell motility, phagocytosis, membrane trafficking, and neurodevelopment. It is expressed predominantly in the brain and is implicated in various cancers and neurological disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various types) Altered expression affects cell proliferation, migration, and invasion Multiple studies (e.g., PMID: 23455423, 25605247)
Schizophrenia Genetic association and differential expression in brain GWAS and expression studies (e.g., PMID: 25056061)
Alzheimer's disease Potential role in synaptic function and amyloid pathology Expression studies (e.g., PMID: 22020298)
Neural tube defects Involvement in neural development Animal model studies (e.g., PMID: 10433909)

Expression Profile

Tissue Expression
Tissue nTPM level
Brain High (e.g., 100+ nTPM) Highest expression in cerebral cortex, hippocampus
Lung Moderate (e.g., 20-50 nTPM) Detectable in alveolar cells
Kidney Low (e.g., 10-20 nTPM) Present in tubular cells
Liver Low (e.g., <10 nTPM) Minimal expression
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) High Neuronal-like expression
HeLa (cervical carcinoma) Moderate Detectable expression
A549 (lung carcinoma) Low Weak expression
MCF7 (breast carcinoma) Moderate Expression varies with subtype
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.123C>T (p.Ser41Leu) Missense Rare (0.01% in gnomAD) Potential effect on calmodulin binding
c.456G>A (p.Thr152Thr) Synonymous 0.5% in gnomAD No known functional effect
c.789delC (p.Pro264fs) Frameshift Very rare Predicted loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift or nonsense mutations leading to truncated protein are likely loss-of-function, affecting actin binding and cell motility.

Gain of Function (GOF)

No clear gain-of-function mutations reported; overexpression in cancer may act as oncogenic driver.

Dominant Negative (DN)

Missense mutations in the calmodulin-binding domain could act dominant-negative by sequestering calmodulin.

Gene Ontology (GO)

• calmodulin binding • actin binding
• protein kinase C binding • phosphatidylserine binding
• signal transduction • cell motility
• neurogenesis • membrane organization

Pathways

MARCKS signaling
Calmodulin signaling
Actin cytoskeleton regulation
PKC signaling
Neuronal development

Protein Summary

MARCKSL1 is a 200-amino acid protein (UniProt P49006) that contains an N-terminal myristoylation motif, a calmodulin-binding domain, and a basic effector domain. It is a substrate of protein kinase C and is involved in actin crosslinking and membrane ruffling. The protein is highly expressed in the brain and plays roles in neurite outgrowth, synaptic plasticity, and phagocytosis. Its dysregulation is linked to cancer metastasis and neuropsychiatric disorders.

Related Products

Product name Cat.No. Species Gene ID
MARCKSL1 Knockout HEK293 Cell Line EDJ-KQ12042 Human 65108 Details Get a Quote
MARCKSL1 Knockout HeLa Cell Line EDJ-KQ39414 Human 65108 Details Get a Quote
MARCKSL1 Knockout A-549 Cell Line EDJ-KQ40673 Human 65108 Details Get a Quote
MARCKSL1 Knockout HCT 116 Cell Line EDJ-KQ40674 Human 65108 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: